| |
| |
|
| Insider
Information: |
Donadio Jamie A |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
221 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,973 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
221 |
|
|
| Total
Value |
$12,973 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mirati Therapeutics, Inc. |
MRTX |
|
2019-05-16 |
221 |
2018-03-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRTX |
Mirati Therapeutics, Inc. |
Sr. VP, CFO |
• – – |
2019-05-16 |
4 |
OE |
$5.50 |
$41,250 |
D/D |
7,500 |
7,721 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Sr. VP, CFO |
• – – |
2019-05-16 |
4 |
AS |
$75.00 |
$562,500 |
D/D |
(7,500) |
221 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Sr. VP, CFO |
• – – |
2019-02-15 |
4 |
OE |
$5.40 |
$40,500 |
D/D |
7,500 |
7,721 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Sr. VP, CFO |
• – – |
2019-02-15 |
4 |
AS |
$75.00 |
$562,502 |
D/D |
(7,500) |
221 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Sr. VP, CFO |
• – – |
2018-03-09 |
4 |
OE |
$17.41 |
$210,661 |
D/D |
12,100 |
12,100 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Sr. VP, CFO |
• – – |
2018-03-09 |
4 |
AS |
$35.00 |
$423,500 |
D/D |
(12,100) |
0 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Sr. VP, CFO |
• – – |
2018-03-01 |
4 |
OE |
$5.40 |
$338,063 |
D/D |
51,875 |
51,875 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Sr. VP, CFO |
• – – |
2018-03-01 |
4 |
AS |
$26.78 |
$1,407,145 |
D/D |
(51,875) |
0 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
